NEW YORK–(BUSINESS WIRE)–Cresso Health, a technology-enabled provider of sales and marketing solutions for leading health insurance carriers in the United States, today announced it has acquired Florida-based GPS Insurance (“GPS”), a distributor of health insurance and related products. Cresso Health is backed by New York-based healthcare investor Cypress Ridge Capital. Kevin Reich, Founder of GPS, … [Read more…]
Company advances commercialization in China through Targeted Collaboration Agreement with Johnson & Johnson SHANGHAI–(BUSINESS WIRE)–#artificialintelligence—Ronovo Surgical, a global innovator in next-generation surgical robotics, announced today the successful closing of its Series D financing, led by Johnson & Johnson’s corporate venture capital organization, JJDC, and participation from Lilly Asia Ventures, INCE Capital and Granite Asia, with … [Read more…]
IRVINE, Calif.–(BUSINESS WIRE)–$RCM #Accreda—Cosentus Holdings, a premier provider in revenue cycle management (RCM) and integrated business solutions for healthcare practices, has announced a strategic investment in Accreda Healthcare Management — a purpose-built company specializing exclusively in anesthesia-focused revenue cycle management. This partnership marks a significant milestone in Cosentus’ commitment to deepening its specialization and elevating … [Read more…]
LatchBio provides white-labeled data infrastructure, analysis tools and delivery portals for kit, instrument, and solution providers. Today, LatchBio released a 25 million cell spatial atlas spanning 11 spatial transcriptomics technologies, including 10X Genomics Visium, Visium HD, Xenium, Bruker Spatial CosMx, STOmics Stereo-seq, Vizgen MERSCOPE, Takara Bio Seeker, AtlasXOmics DBiT-seq, Spatial Genomics GenePS (seqFISH), Element Biosciences … [Read more…]
The importance of glutamate release modulation by evenamide used as an add-on therapy for patients with schizophrenia inadequately responding to their second-generation antipsychotics, including clozapine (study 008A) – oral and poster presentation The key features of a landmark, potentially pivotal, randomized, double-blind, placebo-controlled study designed to demonstrate the short and long-term efficacy and tolerability of … [Read more…]
The wearable baby monitor trusted by millions globally expands reach to three continents, including North America, Europe, and now Africa. JOHANNESBURG–(BUSINESS WIRE)–Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announces the launch of medically-certified Dream Sock™ in South Africa. Distributed as a Class C Medical Device with CE Marking, … [Read more…]
– In AVONELLE-X, the largest long-term extension trial in wet AMD, disease control and durability were maintained over 4 years, with nearly 80% of patients on extended dosing by study end – – Over 60% of people with a difficult-to-treat form of wet AMD showed no signs of damaging lesions in the SALWEEN study, and … [Read more…]
HUAIAN, China–(BUSINESS WIRE)–#2ndJiangsuProvincePetEconomicDevelopmentConference–Deok-ho Lim, director at SV Cross-border Group, a company specializing in the international expansion of hospitals and veterinary clinics in Asia, gave a keynote address at the “2nd Jiangsu Province Pet Economic Development Conference,” where he declared, “The era of searching is over, and the era of answering has arrived.” Lim, who is … [Read more…]
MILPITAS, Calif.–(BUSINESS WIRE)–#DiscoverAmazing–Zepp Health (NYSE: ZEPP), the parent company of Amazfit, today announced it has acquired the core assets and intellectual property of Wild.AI, a pioneering women’s wellness platform focused on optimizing female performance through hormone-informed coaching. The acquisition was completed at the end of August and includes Wild.AI’s proprietary technology and select members of … [Read more…]
MENLO PARK, Calif.–(BUSINESS WIRE)–Octave Bioscience, Inc., a commercial stage precision care company that is pioneering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, today announces the close of its $35.6 million Series C equity financing and that it has entered into a $15.5 million non-dilutive term loan agreement with Silicon Valley … [Read more…]
